miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2

Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions

(2019) Sachiko Matsuhashi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

(2018) Yulin Wang et al.   BMC CANCER

HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation

(2018) Emeline Bollaert et al.   CELLULAR SIGNALLING

AML refractory to primary induction with Ida-FLAG has a poor clinical outcome

(2018) Simon Kavanagh et al.   LEUKEMIA RESEARCH

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

(2018) Mojca Jongen-Lavrencic et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma

(2018) Anita G. Seto et al.   BRITISH JOURNAL OF HAEMATOLOGY

ArrayExpress update – from bulk to single-cell expression data

(2018) Awais Athar et al.   NUCLEIC ACIDS RESEARCH

mixOmics: An R package for ‘omics feature selection and multiple data integration

(2017) Florian Rohart et al.   PLoS Computational Biology

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview

(2017) Martino Marco Gabra et al.   Frontiers in Oncology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

(2016) Hartmut Döhner et al.   BLOOD

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

(2016) Paul Ferguson et al.   HAEMATOLOGICA

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

(2016) Paul Ferguson et al.   HAEMATOLOGICA

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2

(2015) Zhongyi Tong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012

(2015) A G Dinmohamed et al.   LEUKEMIA

Acute Myeloid Leukemia

(2015) Hartmut Döhner et al.   NEW ENGLAND JOURNAL OF MEDICINE

miR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4

(2014) Wenhao Ren et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN

(2013) Shou-mei Yang et al.   TOXICOLOGY

Mechanisms and insights into drug resistance in cancer

(2013) Hiba Zahreddine et al.   Frontiers in Pharmacology

Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling

(2011) Violaine Havelange et al.   CANCER

The prognostic and functional role of microRNAs in acute myeloid leukemia

(2010) G. Marcucci et al.   BLOOD

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

(2010) Y Tomimaru et al.   BRITISH JOURNAL OF CANCER

Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line

(2010) Haitao Bai et al.   FEBS LETTERS

Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis

(2010) Yumin Li et al.   Hematology

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

(2010) N. Valeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD

MicroRNAs: new players in acute myeloid leukaemia

(2009) V Havelange et al.   BRITISH JOURNAL OF CANCER

Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells

(2009) Stéphane Belin et al.   PLoS One

ADP Ribosylation Factor Like 2 (Arl2) Regulates Breast Tumor Aggressivity in Immunodeficient Mice

(2009) Anne Beghin et al.   PLoS One

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

(2008) M. Jongen-Lavrencic et al.   BLOOD